These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 20633178)

  • 1. Botulinum toxin assessment, intervention and follow-up for paediatric upper limb hypertonicity: international consensus statement.
    Fehlings D; Novak I; Berweck S; Hoare B; Stott NS; Russo RN;
    Eur J Neurol; 2010 Aug; 17 Suppl 2():38-56. PubMed ID: 20633178
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Botulinum toxin assessment, intervention and aftercare for cervical dystonia and other causes of hypertonia of the neck: international consensus statement.
    Novak I; Campbell L; Boyce M; Fung VS;
    Eur J Neurol; 2010 Aug; 17 Suppl 2():94-108. PubMed ID: 20633181
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Botulinum toxin assessment, intervention and after-care for upper limb hypertonicity in adults: international consensus statement.
    Sheean G; Lannin NA; Turner-Stokes L; Rawicki B; Snow BJ;
    Eur J Neurol; 2010 Aug; 17 Suppl 2():74-93. PubMed ID: 20633180
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Botulinum toxin assessment, intervention and after-care for lower limb spasticity in children with cerebral palsy: international consensus statement.
    Love SC; Novak I; Kentish M; Desloovere K; Heinen F; Molenaers G; O'Flaherty S; Graham HK;
    Eur J Neurol; 2010 Aug; 17 Suppl 2():9-37. PubMed ID: 20633177
    [TBL] [Abstract][Full Text] [Related]  

  • 5. International consensus statement for the use of botulinum toxin treatment in adults and children with neurological impairments--introduction.
    Esquenazi A; Novak I; Sheean G; Singer BJ; Ward AB
    Eur J Neurol; 2010 Aug; 17 Suppl 2():1-8. PubMed ID: 20633176
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evidence-based review and assessment of botulinum neurotoxin for the treatment of adult spasticity in the upper motor neuron syndrome.
    Esquenazi A; Albanese A; Chancellor MB; Elovic E; Segal KR; Simpson DM; Smith CP; Ward AB
    Toxicon; 2013 Jun; 67():115-28. PubMed ID: 23220492
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Botulinum toxin assessment, intervention and aftercare for lower limb disorders of movement and muscle tone in adults: international consensus statement.
    Olver J; Esquenazi A; Fung VS; Singer BJ; Ward AB;
    Eur J Neurol; 2010 Aug; 17 Suppl 2():57-73. PubMed ID: 20633179
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment: Botulinum neurotoxin for the treatment of spasticity (an evidence-based review): report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology.
    Simpson DM; Gracies JM; Graham HK; Miyasaki JM; Naumann M; Russman B; Simpson LL; So Y;
    Neurology; 2008 May; 70(19):1691-8. PubMed ID: 18458229
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Botulinum toxins in dentistry--the new paradigm for masticatory muscle hypertonicity.
    Katz H
    Singapore Dent J; 2005 Dec; 27(1):7-12. PubMed ID: 16438262
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evidence-based review and assessment of botulinum neurotoxin for the treatment of urologic conditions.
    Chancellor MB; Elovic E; Esquenazi A; Naumann M; Segal KR; Schiavo G; Smith CP; Ward AB
    Toxicon; 2013 Jun; 67():129-40. PubMed ID: 23415704
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Botulinum toxin assessment, intervention and aftercare for paediatric and adult niche indications including pain: international consensus statement.
    Rawicki B; Sheean G; Fung VS; Goldsmith S; Morgan C; Novak I;
    Eur J Neurol; 2010 Aug; 17 Suppl 2():122-34. PubMed ID: 20633183
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evidence-based review and assessment of botulinum neurotoxin for the treatment of movement disorders.
    Hallett M; Albanese A; Dressler D; Segal KR; Simpson DM; Truong D; Jankovic J
    Toxicon; 2013 Jun; 67():94-114. PubMed ID: 23380701
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Botulinum toxin-A use in paediatric hypertonia: Canadian practice patterns.
    Fehlings D; Narayanan U; Andersen J; Beauchamp R; Gorter JW; Kawamura A; Kiefer G; Mason M; McCormick A; Mesterman R; Switzer L; Watt J
    Can J Neurol Sci; 2012 Jul; 39(4):508-15. PubMed ID: 22728860
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Botulinum toxin for the management of adult patients with upper motor neuron syndrome.
    Esquenazi A; Mayer NH; Elia AE; Albanese A
    Toxicon; 2009 Oct; 54(5):634-8. PubMed ID: 19470335
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Long-term effects of botulinum toxin treatment].
    Krystkowiak P
    Ann Dermatol Venereol; 2009 May; 136 Suppl 4():S86-8. PubMed ID: 19576491
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment: Botulinum neurotoxin in the treatment of autonomic disorders and pain (an evidence-based review): report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology.
    Naumann M; So Y; Argoff CE; Childers MK; Dykstra DD; Gronseth GS; Jabbari B; Kaufmann HC; Schurch B; Silberstein SD; Simpson DM;
    Neurology; 2008 May; 70(19):1707-14. PubMed ID: 18458231
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Botulinum toxin: a new dimension in the treatment of lower urinary tract dysfunction.
    Rajkumar GN; Conn IG
    Urology; 2004 Jul; 64(1):2-8. PubMed ID: 15245922
    [No Abstract]   [Full Text] [Related]  

  • 18. Evidence-based review and assessment of botulinum neurotoxin for the treatment of secretory disorders.
    Naumann M; Dressler D; Hallett M; Jankovic J; Schiavo G; Segal KR; Truong D
    Toxicon; 2013 Jun; 67():141-52. PubMed ID: 23178324
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Botulinum toxin type B in the spastic arm: a randomized, double-blind, placebo-controlled, preliminary study.
    Gracies JM; Bayle N; Goldberg S; Simpson DM
    Arch Phys Med Rehabil; 2014 Jul; 95(7):1303-11. PubMed ID: 24709034
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of rimabotulinum toxin for focal hypertonicity management in children with cerebral palsy with nonresponse to onabotulinum toxin.
    Brandenburg JE; Krach LE; Gormley ME
    Am J Phys Med Rehabil; 2013 Oct; 92(10):898-904. PubMed ID: 23636084
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.